|1.||Michaelis, U: 1 article (01/2006)|
|2.||Brix, G: 1 article (01/2006)|
|3.||Strieth, S: 1 article (01/2006)|
|4.||Werner, A: 1 article (01/2006)|
|5.||Eichhorn, M E: 1 article (01/2006)|
|6.||Sauer, B: 1 article (01/2006)|
|7.||Teifel, M: 1 article (01/2006)|
|8.||Jauch, K-W: 1 article (01/2006)|
|9.||Dellian, M: 1 article (01/2006)|
|10.||Ruhstorfer, H: 1 article (01/2006)|
01/01/2006 - "Immunohistological analysis confirmed a significant reduction of microvessel density in MBT-0206 treated tumors. "
01/01/2006 - "In conclusion, antivascular tumor therapy with MBT-0206 significantly impairs functional tumor microcirculation. "
01/01/2006 - "Twenty-four hours after three intravenous applications of MBT-0206, tumors of treated animals demonstrated a significant decrease of intratumoral blood volume and an increase of vascular permeability in comparison to size-matched control tumors. "
01/01/2006 - "As noninvasive imaging techniques are of critical importance for optimizing antivascular cancer treatment in the clinic, we have evaluated the antivascular effects of MBT-0206 in the A-MEL-3 solid tumor model using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). "
05/20/2004 - "Tumor growth was significantly retarded after treatment with MBT-0206 compared to the treatment with paclitaxel. "
|2.||Body Weight (Weight, Body)